David Shaw’s Carter's CRI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-7,000
Closed -$227K 4620
2025
Q4
$227K Sell
7,000
-1,000
-13% -$31.2K ﹤0.01% 4287
2025
Q3
$226K Buy
+8,000
New +$230K ﹤0.01% 4232
2019
Q1
Sell
-27,500
Closed -$2.25M 3641
2018
Q4
$2.25M Hold
27,500
﹤0.01% 2068
2018
Q3
$2.71M Buy
+27,500
New +$2.91M ﹤0.01% 1982
2016
Q1
Sell
-29,100
Closed -$2.59M 3468
2015
Q4
$2.59M Hold
29,100
﹤0.01% 1926
2015
Q3
$2.64M Buy
+29,100
New +$2.92M ﹤0.01% 1889
2013
Q4
Sell
-20,000
Closed -$1.52M 4483
2013
Q3
$1.52M Hold
20,000
﹤0.01% 2669
2013
Q2
$1.48M Buy
+20,000
New +$1.34M ﹤0.01% 2386

Other funds holding CRI

David Shaw's CRI Position: Q2 2026 in Review

David Shaw reduced its Carter's (CRI) stake by 45% in Q2 2026, selling an estimated $9.92M and leaving 322,420 shares worth $13.3M. The position accounts for 0.01% of the portfolio, ranked #1599.

David Shaw first reported a position in CRI in Q2 2013 and has held it in 41 quarters since. The position peaked at $68.1M in Q2 2016. 285 funds tracked by Wall St. Rank hold CRI as of Q2 2026.

  • David Shaw held 322,420 shares of Carter's worth $13.3M as of Q2 2026.
  • David Shaw sold 262,204 Carter's shares in Q2 2026, an estimated $9.92M.
  • Carter's made up 0.01% of David Shaw's portfolio in Q2 2026, its #1599 holding.
  • David Shaw first reported a position in Carter's in Q2 2013 and has held it in 41 quarters since.
  • David Shaw's Carter's position peaked at $68.1M in Q2 2016.
  • 285 funds tracked by Wall St. Rank held Carter's as of Q2 2026.

Based on D.E. Shaw & Co's 13F filing for Q2 2026, filed 14 Aug 2026.